Ignite Creation Date:
2024-05-05 @ 11:10 PM
Last Modification Date:
2024-10-26 @ 10:30 AM
Study NCT ID:
NCT01275248
Status:
TERMINATED
Last Update Posted:
2013-01-18
First Post:
2011-01-10
Brief Title:
Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder
Sponsor:
Transcept Pharmaceuticals
Organization:
Transcept Pharmaceuticals
Organization Data
Organization:
Transcept Pharmaceuticals
Class:
INDUSTRY
Study ID:
OND-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Transcept Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None